Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1046 studies found for:    Open Studies | "Diabetes Mellitus, Type 2"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Diabetes Mellitus, Type 2"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Arterial Stiffness and Complication Risk in Type 2 Diabetes
Conditions: Diabetes Mellitus, Type 2;   Diabetes Complications;   Diabetic Angiopathies;   Diabetic Nephropathies
Intervention:
2 Not yet recruiting Metformin Extended Release Versus Metformin Immediate Release in Subjects With Type 2 Diabetes (CONSENT)
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Metformin XR;   Drug: Metformin IR
3 Recruiting Safety and Efficacy of Vildagliptin Plus Metformin (SPC) Treatment in Type 2 Diabetes Mellitus Patients
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: Vildagliptin
4 Recruiting Simvastatin and Fenofibrate vs Simvastatin Alone in Patients With Type 2 Diabetes Mellitus and Acute Coronary Syndrome
Conditions: Acute Coronary Syndrome;   Diabetes Mellitus, Type 2;   Hypertriglyceridemia
Interventions: Drug: Fenofibrate;   Drug: Simvastatin
5 Recruiting Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Canagliflozin, 100 mg;   Drug: Canagliflozin, 300 mg;   Drug: Placebo
6 Recruiting A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Canagliflozin in Older Children and Adolescents With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Canagliflozin 100 mg;   Drug: Canagliflozin 50 mg;   Drug: Canagliflozin 300 mg;   Drug: Placebo
7 Recruiting The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study
Conditions: Diabetes Mellitus, Type 2;   Diabetes
Interventions: Drug: Metformin;   Drug: Detemir;   Drug: Liraglutide;   Drug: Insulin Aspart
8 Recruiting A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Canagliflozin, 100 mg;   Drug: Canagliflozin, 300 mg;   Drug: Placebo
9 Not yet recruiting Stress Management Among Latinos With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Intervention: Behavioral: stress management
10 Recruiting Effect of Short-Term Beta-Cell Rest in Adolescents and Young Adults With Type 2 Diabetes Mellitus
Conditions: Obesity;   Overweight;   Diabetes Mellitus, Type 2
Intervention:
11 Unknown  The Effects of Lipoic Acid on Glycaemic Control in Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: Lipoic acid
12 Not yet recruiting GLucobay M - Evaluation Of Safety and Effectiveness in Type 2 Diabetes Not Well Controlled on Monotherapy in Real Life Practice
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: Acarbose/Metformin (Glucobay M, BAY81-9783)
13 Not yet recruiting Albiglutide Versus Placebo Added-on to Basal-Bolus Insulin Therapy in Subjects With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Albiglutide;   Drug: Matching albiglutide placebo
14 Recruiting Intervention Study - Effectiveness of Smartphone Delivered Interval Walking Training to Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Other: Interval walking training;   Other: control
15 Not yet recruiting Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Albiglutide;   Drug: Insulin Glargine and Insulin Lispro
16 Recruiting A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus
Conditions: Diabetes Mellitus, Type 2;   Albuminuria
Interventions: Drug: Placebo;   Drug: Canagliflozin, 100 mg;   Drug: Canagliflozin, 300 mg
17 Unknown  Immunosuppression Impact on the Metabolic Control of First Kidney Transplant Recipients With Pre-Existing Type 2 Diabetes (DM)
Conditions: Kidney Transplant;   Diabetes Mellitus, Type 2;   Diabetic Nephropathy
Interventions: Drug: Cyclosporin;   Drug: Tacrolimus;   Behavioral: Diabetes Education / Management
18 Unknown  Improving the Care of Diabetic Patients: A Randomized Trial of a Family Physician Office-Based Chronic Disease Care Model for Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Other: multidisciplinary approach;   Other: multifactorial approach - for enhanced care group;   Other: reflects current patterns of care
19 Unknown  Sitagliptin in Prevention of Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes
Interventions: Drug: Sitagliptin;   Other: life style modification at base line
20 Recruiting Validation of a Patient Decision Aid for Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Intervention: Behavioral: Use of a PDA to assist shared decision making

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years